Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
Advertisement

Obesity

This Month

CSL chief executive Paul McKenzie in Sydney on Monday.

CSL sees greying population as saviour in Ozempic battle

The biotech giant also outlined an inverse Uber-style surge fee to reward people donating blood outside peak hours.

  • Updated
  • Liam Walsh

I walked off 35 kilos and beat my sugar cravings

Ten years ago, my belly was enormous but when I looked in the mirror, I’d pull in my stomach and think I still looked great. It took a health scare to change my ways.

  • Ian Walker

September

Many people are looking to new drugs to help them lose weight.

Why the Ozempic revolution matters to ASX investors

The debate around the potential for weight-loss drugs to hit sleep apnoea giant ResMed raises important questions for investors as they consider themes like AI.

  • James Thomson

July

Analysis by Sydney’s Daffodil Centre, a world-leading cancer research hub, shows a startling rise in five cancers – bowel, kidney, uterus, gallbladder and pancreas – in younger people over the 30 years to 2021.

The alarming rise of cancer among Australian Millennials

The generation now aged 27 to 42 should be in the peak of health, but their incidence of bowel, uterine, kidney, gallbladder and pancreatic cancer has risen dramatically.

  • Jill Margo

June

Wanna binge-watch streamed movies and TV shows? There’s worse things for the environment.

Teal push for new junk food advertising ban

Sophie Scamps, a former GP and emergency room doctor turned teal MP, says advertisers are targeting Australian kids.

  • Tom McIlroy
Advertisement

May

Ozempic is designed to improve blood sugar levels in adults with type 2 diabetes. Its active ingredient works by inducing the feeling of being satisfied.

‘A victim of its own success’: Inside the great Ozempic shortage

The drug is approved in Australia to treat type 2 diabetes but people have flocked to it for weight loss. That’s raising some hard questions about who should receive it and why.

  • Jill Margo
It’s getting tougher for investors to vault over benchmark indicies.

Top fundies name 16 stocks for tougher markets

Charlie Munger says it’s getting harder to find good returns, but these nine fund managers are looking far and wide for the next great companies. 

  • James Thomson

November 2022

Cost of living has dominated the election campaign - and will after polling day

The tricky food label terms that companies use to mask added sugars

A survey found that switching brands in some products could reduce annual intake by several kilograms.

  • Tom McIlroy
James Muecke estimates that a 20 per cent tax on sugary drinks alone would save $2 billion in healthcare costs nationally.

Why this doctor isn’t pushing for a tax on sugary drinks

Ophthalmologist James Muecke says a better option might be to deny junk food companies tax breaks for marketing and sponsorship activities.

  • Tom McIlroy

October 2022

Burger from Wahlburgers in Sydney.

Less than 7pc of Australians eat a healthy diet

A new scorecard on Australia’s growing obesity epidemic has detailed a backslide on the fight to improve nutrition and prevent disease.

  • Tom McIlroy
Sophie Scamps is an independent running in Mackellar.

Ban junk food ads targeting kids: teal MP

TV ads for food products with low nutritional value should be limited to after 9pm, Mackellar MP Sophie Scamps says

  • Tom McIlroy
Increasing concerns about sugar-free soda.

‘It’s a no-brainer’: how to stem Australia’s obesity epidemic

Australians consume the equivalent of 960 Olympic-sized swimming pools of sugary drinks every year, giving the country one of the highest obesity rates in the world.

  • Tom McIlroy

How many km is a doughnut? Food label debate

Labels explaining how much physical exercise would be required to work off unhealthy food choices will be debated at a major conference.

  • Tom McIlroy

July 2022

Your weight and height are not good indicators of your risk of disease.

Finally, a weight-loss drug that really works – but there’s a catch

Novo Nordisk’s Wegovy uses a hormone to regulate hunger. It’s wildly effective, but is it the right solution to the obesity crisis?

  • Hannah Kuchler
There are things you can do to manage your mental health during the lockdown.

Pandemic delivers ‘marked change’ in excess deaths

Despite increased psychological distress, a major new report showed the pandemic has not led to an increase in deaths by suicide in Australia.

  • Tom McIlroy
Advertisement

March 2022

A new study has found avocado is good for your heart.

30-year study finds avocado smashes risk of heart disease

Eating one avocado a week cuts the risk of heart disease by more than a fifth, according to Harvard scientists.

  • Joe Pinkstone

January 2022

People are eating more junk food during the lockdown, an ABS survey has found

Giving in to food cravings may be good for you

Food cravings are caused by a complex interplay of neurons in your brain, and surrendering to them is not just about a lack of self-control. Avoiding temptation may be the wrong way to deal with it.

  • Tara Parker-Pope

December 2021

Excess weight linked to thyroid cancer, especially in men

Overweight men at added risk of thyroid cancer, new study

Big data study shows two out of five thyroid cancers in men are attributable to their body weight.

  • Jill Margo

June 2021

Your weight and height are not good indicators of your risk of disease.

The new formula to measure obesity

The method used to diagnose obesity has serious limitations, researchers say, but a more accurate tool is already available.

  • Helen Chandler-Wilde

May 2021

AOC CEO Matt Carroll.

AOC asks for extra $314m to boost medal tally

The peak sporting body also wants to play a bigger role in the development of sport, health and education policy.

  • Michael Bleby